Lucira Health LHDX Stock
Lucira Health Price Chart
Lucira Health LHDX Financial and Trading Overview
| Lucira Health stock price | 0.45 USD |
| Previous Close | 0.45 USD |
| Open | 0.49 USD |
| Bid | 0 USD x 1000 |
| Ask | 0 USD x 2200 |
| Day's Range | 0.43 - 0.58 USD |
| 52 Week Range | 0.11 - 4.35 USD |
| Volume | 36.26M USD |
| Avg. Volume | 21.15M USD |
| Market Cap | 18.36M USD |
| Beta (5Y Monthly) | 3.75954 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 0.5 USD |
LHDX Valuation Measures
| Enterprise Value | 26.68M USD |
| Trailing P/E | N/A |
| Forward P/E | -0.94229174 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.08656287 |
| Price/Book (mrq) | 0.30053157 |
| Enterprise Value/Revenue | 0.126 |
| Enterprise Value/EBITDA | -0.203 |
Trading Information
Lucira Health Stock Price History
| Beta (5Y Monthly) | 3.75954 |
| 52-Week Change | -93.67% |
| S&P500 52-Week Change | -1.50% |
| 52 Week High | 4.35 USD |
| 52 Week Low | 0.11 USD |
| 50-Day Moving Average | 0.34 USD |
| 200-Day Moving Average | 1.16 USD |
LHDX Share Statistics
| Avg. Volume (3 month) | 21.15M USD |
| Avg. Daily Volume (10-Days) | 2.61M USD |
| Shares Outstanding | 40.6M |
| Float | 30.26M |
| Short Ratio | 0.24 |
| % Held by Insiders | 10.12% |
| % Held by Institutions | 23.89% |
| Shares Short | 676.85K |
| Short % of Float | 3.76% |
| Short % of Shares Outstanding | 1.66% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2021 |
| Most Recent Quarter (mrq) | September 30, 2022 |
| Next Fiscal Year End | December 31, 2022 |
Profitability
| Profit Margin | -67.54% |
| Operating Margin (ttm) | -64.93% |
| Gross Margin | -18.48% |
| EBITDA Margin | -61.86% |
Management Effectiveness
| Return on Assets (ttm) | -41.79% |
| Return on Equity (ttm) | -112.42% |
Income Statement
| Revenue (ttm) | 212.13M USD |
| Revenue Per Share (ttm) | 5.34 USD |
| Quarterly Revenue Growth (yoy) | 129.59% |
| Gross Profit (ttm) | 11.66M USD |
| EBITDA | -131231000 USD |
| Net Income Avi to Common (ttm) | -143276000 USD |
| Diluted EPS (ttm) | -3.14 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 39.77M USD |
| Total Cash Per Share (mrq) | 0.98 USD |
| Total Debt (mrq) | 48.09M USD |
| Total Debt/Equity (mrq) | 78.98 USD |
| Current Ratio (mrq) | 1.46 |
| Book Value Per Share (mrq) | 1.505 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -82350000 USD |
| Levered Free Cash Flow (ttm) | -49881624 USD |
Profile of Lucira Health
| Country | United States |
| State | CA |
| City | EmeryVille |
| Address | 1412 62nd Street |
| ZIP | 94608 |
| Phone | 510 350 8071 |
| Website | https://www.lucirahealth.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 221 |
Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services. The company offers LUCIRA COVID-19 All-In-One Test Kit, a COVID-19 test kit; and develops influenza A and B viruses test kits. It has a patent license agreement with Eiken Chemical Co., Ltd.; technical services agreement with Jabil, Inc.; and manufacturing services agreement with Jabil MSA. The company was formerly known as DiAssess Inc. and changed its name to Lucira Health, Inc. in January 2020. Lucira Health, Inc. was incorporated in 2013 and is headquartered in Emeryville, California. On February 22, 2023, Lucira Health, Inc., filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Q&A For Lucira Health Stock
What is a current LHDX stock price?
Lucira Health LHDX stock price today per share is 0.45 USD.
How to purchase Lucira Health stock?
You can buy LHDX shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Lucira Health?
The stock symbol or ticker of Lucira Health is LHDX.
Which industry does the Lucira Health company belong to?
The Lucira Health industry is Medical Devices.
How many shares does Lucira Health have in circulation?
The max supply of Lucira Health shares is 40.6M.
What is Lucira Health Price to Earnings Ratio (PE Ratio)?
Lucira Health PE Ratio is 0.00000000 now.
What was Lucira Health earnings per share over the trailing 12 months (TTM)?
Lucira Health EPS is 0 USD over the trailing 12 months.
Which sector does the Lucira Health company belong to?
The Lucira Health sector is Healthcare.
Lucira Health LHDX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Global Select Market Com NQGS | 7876.03 USD — |
-1.61
|
— — | 7852.08 USD — | 7955.84 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}